Following, the complex glembatumumab-vedotin is an antibody-drug conjugate directed against the osteoactivin, overexpressed on the OS cell surface [83], and cytotoxic to the OS cell lines [84] and also to other kinds of cancer, such as breast cancer [85,86]. The gene discussed is GPNMB; the disease is cancer.